钱文斌附属第一医院 | 医学院临床医学· CAR-T治疗· 淋巴瘤免疫治疗· 溶瘤病毒-基因治疗· 白血病靶向治疗个人简介:  主要从事淋巴瘤等血液肿瘤的诊治研究，嵌合抗原受体（CAR-T）细胞治疗难治复发淋巴瘤的临床研究以及溶瘤病毒治疗血液肿瘤的基础研究。学习和工作经历：1992获浙江医科大学内科（血液学）硕士学位；2002年获浙江大学血液学博士学位；2002年在德国基尔大学血液病理所做高级访问学者；1992年至今在浙江大学医学院附属第一医院从事血液病临床和实验研究。2007.02 浙江大学医学院附属第一医院血液科副主任2016.10至今 浙江大学血液病研究所副所长2017.01 至今浙江大学医学院附属第一医院淋巴瘤中心主任教学与课程:血液学进展（博士课程）血液病学（浙大八年制）科研:  近5年来先后承担国家重点研发计划精准医学研究重点专项子课题、国家基金、国家科技支撑项目分课题、省重大与高发疾病防治技术重大科技专项和省自然科学基金杰出青年团队等项目近20项。近5年作为负责人和主要成员获得国家科技进步二等奖1项、省科技进步一等奖2项、省科技进步二等奖2项，第一和通讯作者在国际知名期刊发表SCI论文20余篇，影响因子>5的论文7篇。研究与成果:代表论文：第一及通讯作者发表SCI论文39篇（*通讯作者，#co-first author）。(1) Jin S Wei J You L Liu H Qian W*. Autophagy regulation and its dual role in blood cancers: A novel target for therapeutic development (Review). Oncol Rep. 2018 Jun;39(6):2473-2481.(2) Ni F Huang X Chen Z Qian W* Tong X. Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin. Sci Rep. 2018 Feb 20;8(1):3317.(3) You L Mao L Wei J Jin S Yang C Liu H Zhu L Qian W*. The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses. J Hematol Oncol. 2017 Oct 23;10(1):165.(4) Li Y Yang C Mao L Wang J Li C Qian W* Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor. Medicine (Baltimore). 2017 Sep;96(39):e8091. (5) Li L You LS Mao LP Jin SH Chen XH Qian W* Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro. Acta Pharmacol Sin. 2017 Sep 14. (6) Yang C Huang X Liu H Xiao F Wei J You L Qian W*. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242. Oncotarget. 2017 Jun 13;8(24):39185-39197..(7) You L Qian W# Yang Q Mao L Zhu L Huang X Jin J Meng H. ERG11 gene mutations and MDR1 up-regulation confer pan-azole-resistance in Candida tropicalis causing disseminated candidiasis while on posaconazole prophylaxis in an acute lymphoblastic leukemia patient. Antimicrob Agents Chemother. 2017 May 15.(8)You L Liu H Huang J Xie W Wei J Ye X Qian W*. The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins. Oncotarget. Oncotarget. 2017 Jan 31;8(5):7777-7790. (9)You L Jin S Zhu L Qian W*. Autophagy autophagy-associated adaptive immune responses and its role in hematologic malignancies. Oncotarget. 2017 Feb 14;8(7):12374-12388.(10) Lei W Wang S Yang C Huang X Chen Z He W Shen J Liu X Qian W*. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma. Sci Rep. 2016 Aug 24;6:32174.(11) He W Ye X Huang X Lel W You L Wang L Chen X Qian W*. Hsp90 inhibitor BIIB021 induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells. Int J Oncol. 2016 Feb 8. doi: 10.3892/ijo.2016.3382. (12) Xu G Mao L Liu H Yang M Jin J Qian W*. Sorafenib in combination with low-dose-homoharringtonine as a salvage therapy in primary refractory FLT3-ITD-positive AML: a case report and review of literature. Int J Clin Exp Med. 2015 Nov 15;8(11):19891-4.(13) Xiao F Li Y Xu W You L Yang C Liu H Qian W*. Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB. Oncol Lett. 2016 Jan;11(1):355-359.(14) Xu G Wang B Yang M Qian W*. A rare case of nasopharyngeal carcinoma in a patient with multiple myeloma after treatment by lenalidomide. Int J Clin Exp Pathol. 2015 Nov 1;8(11):15025-9.(15) Klionsky DJ Abdelmohsen K Abe A...... Qian WB et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016 Jan 2;12(1):1-222.(16) Xu G Yang M Qian W*. Long-term disease control in a refractory multiple myeloma patient treated with bortezomib mono-therapy: a case report and review of literature. Int J Clin Exp Med. 2015 Oct 15;8(10):19629-31.(17) Zhou W Zhu W Ma L Xiao F Qian W*. Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein. Oncol Lett. 2015 Nov;10(5):2899-2904.(18) Chen W Lin J Cao H Xu D Xu B Xu L Yue L Sun C Wu G Qian W*. Local and Systemic IKKε and NF-κB Signaling Associated with Sjögrens Syndrome Immunopathogenesis. J Immunol Res. 2015;2015:534648.(19) Zhou YH Feng JY You LS Meng HT Qian WB*. Matrine and CYC116 synergistically inhibit growth and induce apoptosis in multiple myeloma cells. Chin J Integr Med. 2015 Aug;21(8):635-9.(20) Tong Y Zhu W Huang X You L Han X Yang C Qian W*. PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus. Oncol Rep. 2014 Apr;31(4):1581-8. (21) Tong Y You L Liu H Li L Meng H Qian Q Qian W*. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia. Oncotarget. 2013 Jun;4(6):860-74.(22) Cao H Cheng Y You L Qian J Qian W*. Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors. Mol Med Rep. 2013 Jun;7(6):1838-44.(23) Meng H Jin Y Liu H You L Yang C Yang X Qian W*. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt. J Hematol Oncol. 2013 Feb 18;6:18. doi: 10.1186/1756-8722-6-18.(24) Wang S Tan Y Lei W Wang Y Zhou X Jia X Zhang K Chu L Liu X Qian W*. Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect. Hum Gene Ther. 2012;23(9):992-1002(25) You L Wang Y Jin Y Qian W*. Down-regulation of Mcl-1 and Bcl-2 synergizes the apoptosis response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus. Oncol Rep. 2012 Apr;27(4):971-8.(26) Tong Y Liu YY You LS Qian W*. Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin. 2012 Apr;33(4):542-50.(27) Meng HT Zhu L Ni WM You LS Jin J Qian W*. Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*. Acta Pharmacol Sin. 2011 Apr;32(4):503-11.(28) Yang C Tong Y Ni W Liu J Xu W Li L Liu X Meng H Qian W* Inhibition of autophagy induced by overexpression of MDA/Interleukin-24 using a PI3K inhibitor results in significant enhanced antileukmia activity in vivo. Cancer Gene Ther. 2010; 17(2):109-119.(29) Xu WL Jin J Qian W*. Homoharringtonine in combination with cytarabine and aclarubicin as induction therapy improves remission and survival of patients with higher risk myelodysplastic syndromes. Chin Med J (Engl). 2010;123(1):108-110.(30) Jin J Liu H Yang C Li G Liu X Qian Q Qian W* Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation. Mol Cancer Ther. 2009; 8(5):1387-1397.(31) Wang G Li G Liu H Yang C Yang X Jin J Liu X Qian Q Qian W* E1B 55-kDa deleted Ad5/F35 fiber chimeric adenovirus a potential oncolytic agent for B-lymphocytic malignancies. J Gene Med. 2009;11:477-485.(32) Li GC Li N Zhang YH Li X Wang YG Liu XY Qian W* Liu XC. Mannose-exposing acute myeloid leukemia cells detected by the sCAR-PPA fusion protein. Int J Hematol. 2009; 89:611-617.(33) Meng HT Li L Liu H Wang Y Li GC Qian W*. Homoharringtonine acts synergistically with SG235-TRAIL a conditionally replicating adenovirus in the treatment of leukemia. Acta Pharmacol Sin. 2009; 11:1529-1536. (34) Qian W* Liu J Tong Y Yan S Yang C Yang M Liu X. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia. 2008; 22: 361-369.(35) Meng H Yang C Jin J Zhou Y Qian W*. Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Leuk Lymphoma. 2008;49:1954-1962.(36) Jiao Y Zhang W Liu J Ni W Xu W Jin J Qian W*. Telomere Attrition and Chromosome Instability via Downregulation of TRF2 Contributes to Arsenic Trioxide-Induced Apoptosis of Human T-Cell Leukemia Cell Line Molt-4 Cells. Cancer Biol Ther. 2007;6:1186-1192.(37) Qian W* Liu J Jin J Ni W Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk Res. 2007;31:329-339.(38) Meng H Yang C Ni W Ding W Yang X Qian W*. Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo. Eur J Haematol. 2007;79:486-493.(39) Yang X Yang C Shao K Ye X Meng H Zhou Y Qian W*. Refractory multiple myeloma treated with homoharringtonine: report of two cases. Ann Hematol. 2007;86:919-921.